Medical Equipment

Mechanical Circulatory Support Devices Market Expected to Record Steady Growth and Approach $5.59 Billion by 2030

March 13, 2026March 16, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Mechanical Circulatory Support Devices Market By 2030 Starting From Its 2026 Size?

The mechanical circulatory support devices market has experienced substantial growth in recent years. Its size is projected to expand from $3.47 billion in 2025 to $3.82 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.1%. Historically, this growth was influenced by the restricted availability of advanced circulatory support devices, a reliance on conventional intra-aortic balloon pumps, an increasing prevalence of heart failure, rising cardiac surgery procedures, and a lack of standardized training for device implantation.

The mechanical circulatory support devices market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach **$5.59 billion in 2030**, demonstrating a compound annual growth rate (CAGR) of **10.0%**. This projected growth is driven by several factors, including technological innovations in both pulsatile and non-pulsatile flow devices, an increase in minimally invasive cardiac procedures, wider acceptance of left and biventricular assist devices, the expansion of healthcare facilities like hospitals and specialized cardiac centers, and increasing financial commitment to research and development in cardiac care. Key trends for this period encompass the growing preference for ventricular assist devices and total artificial hearts, an increase in cardiac surgical operations and heart failure management protocols, the expanded application of extracorporeal membrane oxygenation (ECMO) systems, an emphasis on implementing minimally invasive and percutaneous devices, and improved adherence to regulatory compliance and safety standards for cardiac devices.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27334&type=smp

What Drivers Are Shaping The Future Growth Of The Mechanical Circulatory Support Devices Market?

The increasing incidence of heart failure is anticipated to propel the expansion of the mechanical circulatory support devices market moving forward. Heart failure is a chronic medical condition where the heart is unable to pump sufficient blood to satisfy the body’s demands. The growing occurrence of heart failure is attributed to the aging population, as older individuals are more susceptible to cardiovascular illnesses and associated complications. Mechanical circulatory support devices aid in heart failure management by assisting the heart’s pumping action, improving blood circulation, and alleviating the strain on the weakened heart. For instance, in September 2024, the Heart Failure Society of America (HFSA), a US-based non-profit organization, stated that heart failure currently impacts 6.7 million Americans over 20; this number is projected to rise to 8.7 million by 2030, to 10.3 million by 2040, and to an astonishing 11.4 million by 2050. Consequently, the rising prevalence of heart failure is driving the growth of the mechanical circulatory support devices market.

Which Segment Categories Define The Mechanical Circulatory Support Devices Market?

The mechanical circulatory support devices market covered in this report is segmented –

1) By Type: Intra-Aortic Balloon Pump, Ventricular Assist Device, Total Artificial Heart, Extracorporeal Membrane Oxygenation

2) By Technology: Pulsatile Flow Devices, Non-Pulsatile Flow Devices

3) By Application: Cardiac Surgery, Heart Failure Management, Myocardial Infraction, Cardiogenic Shock

4) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End Users

Subsegments:

1) By Intra-Aortic Balloon Pump: Percutaneous Intra-Aortic Balloon Pump, Surgical Intra-Aortic Balloon Pump

2) By Ventricular Assist Device: Left Ventricular Assist Device, Right Ventricular Assist Device, Biventricular Assist Device

3) By Total Artificial Heart: Pneumatic Total Artificial Heart, Electric Total Artificial Heart

4) By Extracorporeal Membrane Oxygenation: Venoarterial Extracorporeal Membrane Oxygenation, Venovenous Extracorporeal Membrane Oxygenation

What Major Market Trends Are Driving Changes In The Mechanical Circulatory Support Devices Market?

Leading companies in the mechanical circulatory support devices market are concentrating on developing advanced technologies, such as magnetically levitated rotor (MAGLEV) technology, to provide patients with more reliable and efficient devices that boost heart function and improve survival rates. Magnetically levitated rotor (MAGLEV) technology operates by using magnetic fields to suspend and spin a rotor without physical contact, which minimizes friction and wear, leading to smoother, more durable device performance. For instance, in July 2024, BiVACOR Inc., a US-based clinical-stage medical device company, initiated the first-in-human implantation of its Total Artificial Heart (TAH). This innovative device is designed to completely replace both ventricles of a failing heart in patients with severe biventricular or univentricular heart failure who are ineligible for conventional left ventricular assist devices, offering a vital bridge-to-transplant solution that has the potential to enhance survival and quality of life for thousands of patients facing limited treatment options due to the scarcity of donor hearts.

Who Are The Top Companies Competing In The Mechanical Circulatory Support Devices Market?

Major companies operating in the mechanical circulatory support devices market are Abbott Laboratories, Medtronic Plc, Getinge AB, LivaNova PLC, Magenta Medical Ltd., CorWave SA, Jarvik Heart Inc., Carmat SAS, Procyrion Inc., BiVACOR Inc., Evaheart Inc., ReliantHeart Inc., SynCardia Systems LLC, Berlin Heart GmbH, NovaPump GmbH, CardiacAssist Inc., Circulite Medical Inc., Windmill Cardiovascular Systems Inc., NuPulseCV Inc., FineHeart SAS

Read the full mechanical circulatory support devices market report here:

https://www.thebusinessresearchcompany.com/report/mechanical-circulatory-support-devices-global-market-report

Which Geographic Regions Are Influencing Demand In The Mechanical Circulatory Support Devices Market?

North America was the largest region in the mechanical circulatory support devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mechanical circulatory support devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Mechanical Circulatory Support Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27334&type=smp

Browse Through More Reports Similar to the Global Mechanical Circulatory Support Devices Market 2026, By The Business Research Company

Virtual Payment Pos Terminals Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-payment-pos-terminals-global-market-report

Point Of Sale Terminals Market Report 2026

https://www.thebusinessresearchcompany.com/report/point-of-sale-terminals-global-market-report

Proximity Payment Market Report 2026

https://www.thebusinessresearchcompany.com/report/proximity-payment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795